By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272





Gilead (Durham, NC) 

Company News
Astellas (ALPMY) Renews Commitment With CUA-CUOG To Advance Uro-Oncology Research In Canada 12/5/2016 10:22:21 AM
Astellas (ALPMY) And #Baskets4Bros Raise $50,000 For Movember With Toronto Raptors Fans 12/1/2016 12:39:07 PM
Holding Onto Billions, Astellas (ALPMY) CEO Hunts for Next Blockbuster 11/30/2016 7:53:16 AM
Astellas (ALPMY) Extends Commitment With The Canadian Urological Association To Advance Research In Canada 11/18/2016 8:57:33 AM
Astellas (ALPMY) Partners With The Quebec Urological Association Foundation To Advance Urology Research 11/11/2016 11:55:44 AM
Astellas (ALPMY) Establishes Patient Experience Organization In The Americas 11/2/2016 9:28:30 AM
Little-Known Ganymed Grabs a $1.4 Billion Buyout Deal From Astellas (ALPMY) 10/28/2016 5:33:30 AM
Astellas (ALPMY) Release: FDA Approves Supplemental New Drug Application For XTANDI (Enzalutamide) Capsules In Advanced Prostate Cancer 10/21/2016 10:52:26 AM
World Anti-Doping Agency And Astellas (ALPMY) Announce Global Initiative To Prevent Misuse And Abuse Of Medicines For Doping In Sports 10/14/2016 11:57:40 AM
Chromocell And Astellas (ALPMY) Announce FDA Fast Track Designation And First Subject Dosing With Lead Candidate CC8464/ASP1807 For The Management Of Neuropathic Pain Associated With iSFN 10/13/2016 6:48:44 AM